Astra says looks at "everything", silent on Amylin

LONDON (Reuters) - AstraZeneca , which plans to buy Ardea Biosciences for $1.26 billion (782.8 million pounds), is also looking at a range of other biotech assets - but its research head would not be drawn on interest in Amylin Pharmaceuticals . Amylin has started reaching out to potential buyers after spurning a $3.5 billion takeover bid from Bristol-Myers Squibb , sources familiar with the situation said at the weekend. Analysts have speculated that Amylin could be attractive to AstraZeneca, given the two companies' shared interest in diabetes. ...

Source: http://uk.news.yahoo.com/astra-says-looks-everything-silent-amylin-090057635--finance.html

Workout Beautiful, Dirty, Rich I Will Not Give Up Whataya Want From Me